OCEANSIDE, N.Y., Feb. 11, 2004 (PRIMEZONE) -- APO Health, Inc. (OTCBB:APOA) announced today that it has engaged the New York-based investment banking firm, Sloan Securities Corp., an NASD member, to advise the Company on growth strategy, mergers & acquisitions, and to assist management in maximizing shareholder value. Sloan, through its merchant banking affiliate, Ocean Drive Capital, specializes in working with micro and small cap companies such as APO Health, Inc. Dan Myers, Managing Director of Investment Banking and a principal in Ocean Drive Capital, said "We are excited about working with APO Health. The outlook today for healthcare companies is very positive and we believe that APO is in an excellent position to take advantage of this environment."
APO Health Inc.
APO Health Inc. is a multifaceted distributor of medical, dental and veterinary supplies, health and beauty aids, and pharmaceutical products. The Company distributes over 6,000 different products, marketing directly to doctors, dentists, schools and retail outlets as well as through other distributors. Net sales for the year ended September 30, 2003 were $47.5 million.
Safe Harbor Statement
The statements made by APO Health, Inc. may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe the Company's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APO Health, Inc. Actual results could differ materially from those projected due to changes in interest rates, market competition, changes in the local and national economies, and various other factors. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.